1406 related articles for article (PubMed ID: 32103760)
21. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
22. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
24. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
[TBL] [Abstract][Full Text] [Related]
26. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
[TBL] [Abstract][Full Text] [Related]
27. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
[TBL] [Abstract][Full Text] [Related]
28. HSF1 expression in tumor-associated macrophages promotes tumor cell proliferation and indicates poor prognosis in esophageal squamous cell carcinoma.
Li Y; Li Q; Liu J; Huang Y; Mao J; Zhang G
Clin Transl Oncol; 2023 Jun; 25(6):1682-1689. PubMed ID: 36586067
[TBL] [Abstract][Full Text] [Related]
29. Tumor associated macrophages in esophageal squamous carcinoma: Promising therapeutic implications.
Zhang J; Dong Y; Di S; Xie S; Fan B; Gong T
Biomed Pharmacother; 2023 Nov; 167():115610. PubMed ID: 37783153
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy B; Lawrence T; Dean DC; Postigo A
EMBO J; 2017 Nov; 36(22):3336-3355. PubMed ID: 29038174
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma.
Koga N; Hu Q; Sakai A; Takada K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Oki E; Oda Y; Mori M
Cancer Sci; 2021 Aug; 112(8):3018-3028. PubMed ID: 34009732
[TBL] [Abstract][Full Text] [Related]
32. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
Li S; Liu Z; Chen Q; Chen Y; Ji S
Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
[TBL] [Abstract][Full Text] [Related]
33. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
34. HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
Yuan X; Liu K; Li Y; Zhang AZ; Wang XL; Jiang CH; Liang WH; Zhang HJ; Pang LJ; Li M; Yang L; Qi Y; Zheng Q; Li F; Hu JM
Clin Transl Oncol; 2021 Nov; 23(11):2382-2393. PubMed ID: 34075547
[TBL] [Abstract][Full Text] [Related]
35. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
36. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
[TBL] [Abstract][Full Text] [Related]
37. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
38. CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages.
Yang Z; Li H; Wang W; Zhang J; Jia S; Wang J; Wei J; Lei D; Hu K; Yang X
Front Oncol; 2019; 9():231. PubMed ID: 31024838
[No Abstract] [Full Text] [Related]
39. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
[TBL] [Abstract][Full Text] [Related]
40. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
